TIF Shares Position Statement Urging Health Authorities to Identify Thalassemia/SCD Patients as High Risk of COVID-19

April 21, 2020 – TIF has created a Position Statement in which it encourages national health authorities worldwide to include patients with thalassemia and sickle cell disease in the group of patients considered high risk/vulnerable to COVID-19. It is hoped that such a request will lead to increased vigilance and prevention measures on behalf of these patients in treatment centers. Further details can be found in the Position Statement linked below.

Secured By miniOrange